The investigators will determine whether an acute dose of nicotine, in the form of the nicotine lozenge, impacts brain and behavioral measures of mood and reward responsiveness in individuals with major depressive disorder.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
46
Single Acute dose
McLean Hospital
Belmont, Massachusetts, United States
Change from Placebo in functional magnetic resonance imaging (fMRI) BOLD Response
Nicotine will enhance the fMRI BOLD response to monetary reinforcers relative to placebo administration
Time frame: Participants will be assessed during 2 fMRI scanning sessions, an expected average of 2 weeks.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.